New

Middle East and Africa Immunohistochemistry Market

2021

Middle East and Africa Immunohistochemistry Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Diagnostics and Drug Testing), Product (Antibodies, Equipment, Reagents, and Kits), and End User (Hospitals and Diagnostic Laboratories, Research Institutes, and Others)

Publication Month: Nov 2021 | Report Code: TIPRE00025749 | No. of Pages: 150 | Category: Biotechnology | Status: Published

Market Insights

Middle East and Africa Immunohistochemistry Market to Grow at a CAGR of 6.3% to reach US$ 136.50 million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The MEA immunohistochemistry market is expected to grow from US$ 88.98 million in 2021 to US$ 136.50 million by 2028; it is estimated to grow at a CAGR of 6.3% from 2021 to 2028.

The UAE, South Africa, and Saudi Arabia are major economies in MEA. Rising acceptance of automation in immunohistochemistry is expected to fuel the market growth. Traditional diagnostic tests were generally conducted in laboratories with expensive equipment and staffed with trained personnel accountable for performing the tests. Since the last few decades, diagnostic testing has gradually progressed out of the central laboratory and into testing sites, which is close to patients. The rising demand for immunohistochemistry, coupled with a shortage of working staffs in the immunology labs, has created a need for automation in immunohistochemistry. Automation in immunohistochemistry (IHC) provides the opportunity to improve sensitivity levels, reproducibility, standardization, as well as offers advantages such as a reduction in working time and saving of reagents. Analytical flexibility is one of the essential factors required in the immunohistochemistry protocols. Automation of the IHC contributes to standardize the immunohistochemical techniques decisively. Moreover, it also helps to simplify 16-step manual methods to 5-step methods that help to minimize the number of working personnel. Furthermore, the automated immunohistochemistry ensures consistent quality and discharge of stains and improves the standardization and optimization of the different techniques. Moreover, with reliable and fast results, automation can provide diagnostic test results at better speed, leading to shortening the period of hospitalization, resulting in cost-savings. Thus, various benefits offered by automation in immunohistochemistry (IHC) are likely to be accepted and act as one of the prevalent trends in the MEA market over the coming years.

In case of COVID-19, MEA is highly affected especially South Africa. Economic uncertainties and ongoing conflicts are worsening the condition in the region. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflicts and cannot implement robust public health measures. Iran was in deep economic recession due to the US sanctions. Also, the major source of economic stabilization in Middle East countries is oil production and export. However, the recent pandemic is causing turbulence to the economies of the Middle East. A sudden drop in domestic and external demand for goods and products, especially crude oil, and halted production due to labor shortage, are major impacts observed in the region. The spread of coronavirus in the region caused heavy burdens on healthcare professionals. Cardiac surgeons were overloaded with emergency cardiac surgeries, management of coronavirus patients, and implementation of safety guidelines to prevent the spread of virus. Rapid spread to virus impacted to elective surgeries. These factors are projected to hamper the growth of MEA immunohistochemistry market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA immunohistochemistry market. The MEA immunohistochemistry market is expected to grow at a good CAGR during the forecast period.
 MEA immunohistochemistry market

Get more information on this report :


MEA Immunohistochemistry Market Segmentation

MEA Immunohistochemistry Market – By Product

  • Equipment
    • Slide Staining Systems
    • Tissue Microarray Systems
    • Tissue Processing Systems
    • Slide Scanners
    • Other Equipment
  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Reagents
    • Histological Stains
    • Blocking and Fixation Reagents
    • Chromogenic Substrates
    • Fixation Reagents
    • Stabilizers
    • Organic Solvents
    • Proteolytic Enzymes
    • Diluents
  • Kits

MEA Immunohistochemistry Market – By Application

  • Diagnostics
    • Cancer
    • Infectious Diseases
    • Autoimmune Diseases
    • Diabetes Mellitus
    • Nephrological Diseases
    • Others
  • Drug Testing

MEA Immunohistochemistry Market – By End User

  • Hospitals and Diagnostic Laboratories
  • Research Institutes
  • Others

MEA Immunohistochemistry Market, by Country

  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA

MEA Immunohistochemistry Market - Companies Mentioned

  • Abcam plc
  • Agilent Technologies, Inc.
  • Bio SB
  • BIO-RAD LABORATORIES INC.
  • Danaher
  • F. HOFFMANN-LA ROCHE LTD.
  • MERCK KGaA
  • PerkinElmer Inc.
  • THERMO FISHER SCIENTIFIC INC.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 MEA Immunohistochemistry Market – By Product

1.3.2 MEA Immunohistochemistry Market – By Application

1.3.3 MEA Immunohistochemistry Market – By End User

1.3.4 MEA Immunohistochemistry Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. MEA Immunohistochemistry Market – Market Landscape

4.1 Overview

4.2 MEA PEST Analysis

4.3 Experts Opinion

5. MEA Immunohistochemistry Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Surging Incidences of Chronic and Infectious Diseases

5.1.2 Escalating R&D Investments by Biotechnology & Biopharmaceutical Companies

5.2 Key Market Restraints

5.2.1 Issues Related to Immunohistochemistry

5.3 Key Market Opportunities

5.3.1 Growing Opportunities in Emerging Countries

5.4 Future Trends

5.4.1 Rising Acceptance of Automation in Immunohistochemistry

5.5 Impact Analysis

6. Immunohistochemistry Market – MEA Analysis

6.1 MEA Immunohistochemistry Market Revenue Forecast and Analysis

7. MEA Immunohistochemistry Market Analysis– By Product

7.1 Overview

7.2 MEA Immunohistochemistry Market, By Product 2021 & 2028 (%)

7.3 Antibodies

7.3.1 Overview

7.3.2 Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.3 Primary Antibodies

7.3.3.1 Overview

7.3.3.2 Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.4 Secondary Antibodies

7.3.4.1 Overview

7.3.4.2 Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4 Equipment Market

7.4.1 Overview

7.4.2 Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.3 Slide Staining Systems

7.4.3.1 Overview

7.4.3.2 Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.4 Tissue Microarrays

7.4.4.1 Overview

7.4.4.2 Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.5 Tissue Processing Systems

7.4.5.1 Overview

7.4.5.2 Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.6 Slide Scanners

7.4.6.1 Overview

7.4.6.2 Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.7 Other Equipments

7.4.7.1 Overview

7.4.7.2 Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5 Reagents Market

7.5.1 Overview

7.5.2 Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.3 Histological Stains

7.5.3.1 Overview

7.5.3.2 Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.4 Blocking Sera & Reagents Market

7.5.4.1 Overview

7.5.4.2 Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.5 Chromogenic Substrates Market

7.5.5.1 Overview

7.5.5.2 Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.6 Stabilizers

7.5.6.1 Overview

7.5.6.2 Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.7 Proteolytic Enzymes

7.5.7.1 Overview

7.5.7.2 Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.8 Organic Solvents

7.5.8.1 Overview

7.5.8.2 Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.9 Fixation Reagents

7.5.9.1 Overview

7.5.9.2 Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.10 Diluents

7.5.10.1 Overview

7.5.10.2 Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.6 Kits Market

7.6.1 Overview

7.6.2 Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

8. MEA Immunohistochemistry Market Analysis – By Application

8.1 Overview

8.2 MEA Immunohistochemistry Market Share by Application 2021 & 2028 (%)

8.3 Diagnostics

8.3.1 Overview

8.3.2 Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

8.3.3 Cancer

8.3.3.1 Overview

8.3.3.2 Cancer Market Revenue and Forecast to 2028 (US$ Mn)

8.3.4 Infectious Diseases

8.3.4.1 Overview

8.3.4.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.5 Autoimmune Diseases

8.3.5.1 Overview

8.3.5.2 Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.6 Diabetes Mellitus

8.3.6.1 Overview

8.3.6.2 Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)

8.3.7 Nephrological Diseases

8.3.7.1 Overview

8.3.7.2 Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.8 Others

8.3.8.1 Overview

8.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Drug Testing

8.4.1 Overview

8.4.2 Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)

9. MEA Immunohistochemistry Market Analysis– By End User

9.1 Overview

9.2 MEA Immunohistochemistry Market, By End User 2021 & 2028 (%)

9.3 Hospital & Diagnostic Laboratories

9.3.1 Overview

9.3.2 Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.4 Research Institutes

9.4.1 Overview

9.4.2 Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.5 Others

9.5.1 Overview

9.5.2 Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10. MEA Immunohistochemistry Market – Country Analysis

10.1 MEA Immunohistochemistry Market Revenue and Forecasts To 2028

10.1.1 MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1 UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.1 UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.2 UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.1.2.1 UAE Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.1.2.2 UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.1.2.3 UAE Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.1.3 UAE Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.1.3.1 UAE Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.1.4 UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.1.2 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.1 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.2 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.2.2.1 Saudi Arabia Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.2.2.2 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.2.2.3 Saudi Arabia Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.2.3 Saudi Arabia Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.2.3.1 Saudi Arabia Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.2.4 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.1.3 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.1 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.2 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.3.2.1 South Africa Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.3.2.2 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.3.2.3 South Africa Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.3.3 South Africa Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.3.3.1 South Africa Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.3.4 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.1.4 Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.1 Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.2 Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.4.2.1 Rest of MEA Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.4.2.2 Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.4.2.3 Rest of MEA Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.4.3 Rest of MEA Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.4.3.1 Rest of MEA Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.4.4 Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on MEA Immunohistochemistry Market

11.1 MEA: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic developments

12.3.1 Overview

13. Company Profiles

13.1 F. HOFFMANN-LA ROCHE LTD.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 MERCK KGaA

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 PerkinElmer Inc.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 THERMO FISHER SCIENTIFIC INC.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Abcam plc

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Agilent Technologies, Inc.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 BIO-RAD LABORATORIES INC.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Danaher

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Bio SB

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. MEA Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Table 2. UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 3. UAE Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 4. UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 5. UAE Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 6. UAE Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 7. UAE Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 8. UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 9. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 10. Saudi Arabia Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 11. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 12. Saudi Arabia Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 13. Saudi Arabia Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 14. Saudi Arabia Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 15. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 16. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 17. South Africa Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 18. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 19. South Africa Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 20. South Africa Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 21. South Africa Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 22. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 23. Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 24. Rest of MEA Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 25. Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 26. Rest of MEA Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 27. Rest of MEA Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 28. Rest of MEA Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 29. Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 30. Organic Developments Done By Companies

Table 31. Inorganic developments done by Companies

Table 32. Glossary of Terms

LIST OF FIGURES

Figure 1. MEA Immunohistochemistry Market Segmentation

Figure 2. MEA Immunohistochemistry Market Segmentation, By Country

Figure 3. MEA Immunohistochemistry Market Overview

Figure 4. Antibodies Segment Held the Largest Share of the Market in 2021

Figure 5. The UAE to Show Significant Growth During Forecast Period

Figure 6. MEA PEST Analysis

Figure 7. Impact Analysis of Drivers and Restraints Pertaining to MEA Immunohistochemistry Market

Figure 8. MEA Immunohistochemistry Market – Revenue Forecast and Analysis

Figure 9. MEA Immunohistochemistry Market, by Product 2021 & 2028 (%)

Figure 10. MEA Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. MEA Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. MEA Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. MEA Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. MEA Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. MEA Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16. MEA Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. MEA Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. MEA Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19. MEA Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. MEA Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21. MEA Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22. MEA Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. MEA Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24. MEA Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. MEA Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. MEA Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27. MEA Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28. MEA Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. MEA Immunohistochemistry Market Share by Application 2021 & 2028 (%)

Figure 30. MEA Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 31. MEA Cancer Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 32. MEA Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 33. MEA Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 34. MEA Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 35. MEA Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 36. MEA Others Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 37. MEA Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 38. MEA Immunohistochemistry Market, by End User 2021 & 2028 (%)

Figure 39. MEA Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40. MEA Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41. MEA Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42. MEA Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ Mn)

Figure 43. MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

Figure 44. UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 45. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 46. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 47. Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 48. Impact of COVID-19 Pandemic in MEA Country Markets

  1. Abcam plc
  2. Agilent Technologies, Inc.
  3. Bio SB
  4. BIO-RAD LABORATORIES INC.
  5. Danaher
  6. F. HOFFMANN-LA ROCHE LTD.
  7. MERCK KGaA
  8. PerkinElmer Inc.
  9. THERMO FISHER SCIENTIFIC INC.    
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA immunohistochemistry market.      
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the MEA immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies  
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
TIPRE00025749
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.